| Literature DB >> 22738670 |
Waleska Cláudia Dornas1, Wanderson Geraldo de Lima, Rinaldo Cardoso Dos Santos, Melina Oliveira de Souza, Maísa Silva, Mirla Fiuza Diniz, Marcelo Eustáquio Silva.
Abstract
Paraoxonase 1 (PON1) is a HDL-associated esterase/lactonase and its activity is inversely related to the risk of cardiovascular diseases. The aim of the present study was to evaluate the effect of a high-salt diet on serum PON1 activity in fructose-fed insulin-resistant rats. Adult male Fischer rats were initially divided into two groups. Control (CON), which received a normal salt diet and drinking water throughout the study; high fructose (HF), which received a normal salt diet and 20% fructose supplemented drinking water. After 10 weeks, half of the animals from HF group were randomly switched to a high-salt diet and 20% fructose supplemented drinking water (HFS) for more 10 weeks. Serum PON1 activity was determined by synthetic substrate phenyl acetate. HFS rats showed markedly decreased PON1 activity (HFS rats, 44.3 ± 14.4 g/dL versus CON rats, 64.4 ± 13.3 g/dL, P < 0.05) as compared to controls. In parallel, the level of oxidative stress, as indicated by thiobarbituric acid reactive substances (TBARS), was increased in HFS rats by 1.2-fold in the liver in relation to controls and was negatively correlated with PON activity. Differential leukocyte counts in blood showed a significant change in lymphocytes and monocytes profile. In conclusion, these results show that PON1 activity is decreased in fructose-fed insulin-resistant rats on a high-salt diet, which may be associated with increased oxidative stress, leading to inflammation.Entities:
Year: 2012 PMID: 22738670 PMCID: PMC3407710 DOI: 10.1186/1743-7075-9-63
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Serum total protein, albumin, triglyceride, total cholesterol, HDL-cholesterol, atherogenic index and PON1 activity of experimental rats after 20 weeks of treatment
| Number of rats/group | 9 | 10 | 10 |
| Total protein (g/dL) | 7,0 ± 2,0a | 6,3 ± 1,8a | 4,9 ± 1,5b |
| Albumin (g/dL) | 2,8 ± 0,2a | 2,6 ± 0,3a | 2,1 ± 0,2b |
| Triglyceride (mg/dL) | 126,1 ± 30,8b | 183,5 ± 58,7a | 197,1 ± 55,9a |
| Total cholesterol (mg/dL) | 97,9 ± 20,9a | 98,0 ± 13,3a | 69,3 ± 9,0b |
| HDL-cholesterol (mg/dL) | 66,4 ± 10,6a | 65,8 ± 9,4a | 43,6 ± 12,17b |
| Atherogenic index | 0,39 ± 0,12b | 0,47 ± 0,11b | 0,65 ± 0,26a |
| PON1 (g/dL) | 64,45 ± 13,36a | 65,44 ± 17,29a | 44,3 ± 14,43b |
Values (mean ± SD) were obtained from groups CON (AIN diet and water for 20 weeks); HF (AIN diet + 20% fructose solution in water for 20 weeks) and HFS (8% NaCl in AIN93 diet + 20% fructose solution in water for 10 weeks after previous treatment for a period of 10 weeks with HF). Different superscript letters within the same row indicate significant difference at P < 0.05 by one-way ANOVA followed by Tukey’s test. High-density lipoprotein (HDL); paraoxonase1 activity (PON1).
Figure 1(A) Liver TBARS levels; scatter plots illustrating the association between (B) PON1 and total protein and (C) albumin and (D) Total cholesterol and (E) HDL-cholesterol and (F) TBARS in experimental groups. Control (dark filled circle); high-fructose (dark filled triangle) and high-fructose + salt (dark filled square) rats. High-density lipoprotein (HDL); paraoxonase1 activity (PON1).
Polymorphonuclear cells, lymphocytes and monocytes count of experimental rats after 20 weeks of treatment
| PMN cells (%) | 5-15 | 3-27 | 7-23 |
| Lymphocytes (%) | 19-58 | 4-33** | 7-20*** |
| Monocytes (%) | 27-76 | 36-85** | 40-83* |
Values were obtained from groups CON (AIN diet and water for 20 weeks); HF (AIN diet + 20% fructose solution in water for 20 weeks), and HFS (8% high salt in AIN93 diet + 20% fructose solution in water for 10 weeks after previous treatment for a period of 10 weeks with HF). Kruskall Wallis test followed by Dunns test. Values indicate lowest and highest percentage of cells counted respectively. *P < 0.05; **P < 0.01; ***P < 0.001. Polymorphonuclear (PMN) cells.